← Open Payments lookup

MICHELLE ADAMS: Open Payments

NPI 1578586863 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$839 in 29 payments from 11 companies in 2025. Trend: 2023 $718 · 2024 $540 · 2025 $839

Food & beverage: $839
CompanyPaymentsAmount
Gilead Sciences, Inc.4$165
Kowa Pharmaceuticals America, Inc.1$117
ABBVIE INC.6$106
AstraZeneca Pharmaceuticals LP1$101
Merck Sharp & Dohme LLC1$98
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$58
PFIZER INC.3$53
Lilly USA, LLC3$50
Phathom Pharmaceuticals, Inc.3$38
Boehringer Ingelheim Pharmaceuticals, Inc.2$34

Products named: ZORYVE, Yeztugo, BREZTRI, CAPVAXIVE, VRAYLAR, CAPLYTA, MOUNJARO, UBRELVY.

Industry payments across KY — which companies pay providers there.